Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eli Silber

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 17, 2010
Osteoporosis in multiple sclerosisAndrew P Hearn, Eli Silber
BMJ Case Reports|June 28, 2017
Neurogenic pulmonary oedema: a rare cause of maternal collapseHuma Farooq, Sukrutha Veerareddy, Eli Silber
Neurology|April 17, 2015
Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimodTimothy Tully, Alastair Barkley, Eli Silber
Clinical Medicine (London, England)|May 16, 2008
Long-term neurological conditions: management at the interface between neurology, rehabilitation and palliative careLynne Turner-Stokes, Nigel Sykes, Eli Silber, et al.
Practical Neurology|March 30, 2026
Rational sadness in neurological diseaseKimberley Rose Monks, Eli Silber, Emma Husbands
BMJ Case Reports|March 16, 2021
Progressive bulbar symptomatology due to vascular brainstem compressionOsman Younus, Timothy Hampton, Eli Silber, et al.
Multiple Sclerosis and Related Disorders|January 29, 2021
Improving MS patients' understanding of treatment risks and benefits in clinical consultations: A randomised crossover trialGurpreet K Reen, Eli Silber, Dawn W Langdon
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 15, 2018
Best Methods of Communicating Clinical Trial Data to Improve Understanding of Treatments for Patients with Multiple SclerosisGurpreet K Reen, Eli Silber, Dawn W Langdon
Practical Neurology|January 7, 2022
Facial myokymia as the presenting feature of multiple sclerosisAnna-Marie C Parr, James Bashford, Eli Silber
Patient Education and Counseling|January 22, 2017
Interventions to support risk and benefit understanding of disease-modifying drugs in Multiple Sclerosis patients: A systematic reviewGurpreet K Reen, Eli Silber, Dawn W Langdon
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 17, 2010
Osteoporosis in multiple sclerosisAndrew P Hearn, Eli Silber
BMJ Case Reports|June 28, 2017
Neurogenic pulmonary oedema: a rare cause of maternal collapseHuma Farooq, Sukrutha Veerareddy, Eli Silber
Neurology|April 17, 2015
Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimodTimothy Tully, Alastair Barkley, Eli Silber
Clinical Medicine (London, England)|May 16, 2008
Long-term neurological conditions: management at the interface between neurology, rehabilitation and palliative careLynne Turner-Stokes, Nigel Sykes, Eli Silber, et al.
Practical Neurology|March 30, 2026
Rational sadness in neurological diseaseKimberley Rose Monks, Eli Silber, Emma Husbands
BMJ Case Reports|March 16, 2021
Progressive bulbar symptomatology due to vascular brainstem compressionOsman Younus, Timothy Hampton, Eli Silber, et al.
Multiple Sclerosis and Related Disorders|January 29, 2021
Improving MS patients' understanding of treatment risks and benefits in clinical consultations: A randomised crossover trialGurpreet K Reen, Eli Silber, Dawn W Langdon
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 15, 2018
Best Methods of Communicating Clinical Trial Data to Improve Understanding of Treatments for Patients with Multiple SclerosisGurpreet K Reen, Eli Silber, Dawn W Langdon
Practical Neurology|January 7, 2022
Facial myokymia as the presenting feature of multiple sclerosisAnna-Marie C Parr, James Bashford, Eli Silber
Patient Education and Counseling|January 22, 2017
Interventions to support risk and benefit understanding of disease-modifying drugs in Multiple Sclerosis patients: A systematic reviewGurpreet K Reen, Eli Silber, Dawn W Langdon
Pageof 8